Center-Authored Papers

Filters: Author is Rudin, Charles M  [Clear All Filters]
2011
Kalemkerian GP, Akerley W, Bogner P, Borghaei H, Chow L, Downey RJ, Gandhi L, Ganti AKP, Govindan R, Grecula JC et al..  2011.  Small cell lung cancer.. Journal of the National Comprehensive Cancer Network : JNCCN. 9(10):1086-113.
2013
Kalemkerian GP, Akerley W, Bogner P, Borghaei H, Chow LQM, Downey RJ, Gandhi L, Ganti AKP, Govindan R, Grecula JC et al..  2013.  Small cell lung cancer.. Journal of the National Comprehensive Cancer Network : JNCCN. 11(1):78-98. Abstract
Wrangle J, Wang W, Koch A, Easwaran H, Mohammad HP, Vendetti F, Vancriekinge W, Demeyer T, Du Z, Parsana P et al..  2013.  Alterations of immune response of non-small cell lung cancer with Azacytidine.. Oncotarget. 4(11):2067-79. Abstract
2015
Borghaei H, Paz-Ares L, Horn L, Spigel DR, Steins M, Ready NE, Chow LQ, Vokes EE, Felip E, Holgado E et al..  2015.  Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer.. The New England journal of medicine. Abstract
2016
Bunn PA, Minna J, Augustyn A, Gazdar A, Ouadah Y, Krasnow MA, Berns A, Brambilla E, Rekhtman N, Massion PP et al..  2016.  Small Cell Lung Cancer: Can recent advances in biology and molecular biology be translated into improved outcomes? Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 11(4):453-74.
Leighl NB, Rizvi NA, de Lima LG, Arpornwirat W, Rudin CM, Chiappori AA, Ahn M-J, Chow LQM, Bazhenova L, Dechaphunkul A et al..  2016.  Phase 2 Study of Erlotinib in Combination With Linsitinib (OSI-906) or Placebo in Chemotherapy-Naive Patients With Non-Small-Cell Lung Cancer and Activating Epidermal Growth Factor Receptor Mutations.. Clinical lung cancer. Abstract
2019
Augert A, Eastwood E, Ibrahim AH, Wu N, Grunblatt E, Basom R, Liggitt D, Eaton KD, Martins R, Poirier JT et al..  2019.  Targeting NOTCH activation in small cell lung cancer through LSD1 inhibition.. Science signaling. 12(567) Abstract